Show simple item record

Authordc.contributor.authorHasbún, Trinidad
Authordc.contributor.authorChaparro, Ximena
Authordc.contributor.authorKaplan Zapata, Viera
Authordc.contributor.authorCavagnaro, Felipe
Authordc.contributor.authorCastro, Alex
Admission datedc.date.accessioned2018-08-13T18:55:11Z
Available datedc.date.available2018-08-13T18:55:11Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationRev Chil Pediatr. 2018;89(1):103-106es_ES
Identifierdc.identifier.other10.4067/S0370-41062018000100103
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/150940
Abstractdc.description.abstractHenoch-Schonlein purpura (HSP) or IgA Vasculitis is the most common childhood vasculitis. The classic tetrad of signs and symptoms include palpable purpura, arthralgia, abdominal pain and renal disease. The occurrence of hemorrhagic bullae in children with HSP is rarely encountered. Objective: To report an unusual cutaneous manifestation of HSP in children. Case report: A 14-year-old girl complained about a 2-week painful bullous rash in both lower extremities and multiple arthralgias. There was no history of abdominal pain or urinary symptoms. In both lower extremities, there were numerous palpable purpura and hemmorrhagic bullae. In light of clinical findings, laboratory tests and skin biopsy are requested. The histopathology described intraepidermal blisters, acanthosis, spongiosis and perivascular dermal infiltrate. Direct immunofluorescence (IFD) (+) for IgA. The diagnosis of bullous HSP was made and treatment with endovenous corticosteroids was initiated. Three days after overlapping to oral corticosteroids, new ecchymotic lesions appeared in both legs. Due to the persistence of cutaneous involvement and negative control tests, azathioprine was associated obtaining a good response. Conclusion: Although bullous lesions in HSP does not add morbidity, it is often an alarming phenomenon with multiple differential diagnoses. The anti-inflamatory effect of corticoids is likely to be beneficial in the treatment of patients with severe cutaneous involvement through inhibition of proinflammatory transcription factors and decreasing the production of the metalloproteinases.es_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherSociedad Chilena Pediatríaes_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceRevista Chilena de Pediatría-Chilees_ES
Keywordsdc.subjectSchonlein Henoches_ES
Keywordsdc.subjectBullous purpuraes_ES
Keywordsdc.subjectVasculitises_ES
Keywordsdc.subjectBlisterses_ES
Títulodc.titleBullous Henoch-Schonlein purpura. Case reportes_ES
Title in another languagedc.title.alternativePúrpura de Schönlein-Henoch Buloso. Caso clínicoes_ES
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso abierto
Catalogueruchile.catalogadorrgfes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile